logo


22-01-2014

Porocel purchases Canadian catalyst plant and processing facility

Porocel of Canada, Ltd announces the acquisition of the Medicine Hat catalyst processing plant from Criterion Catalysts & Technologies Canada, Inc. Porocel of Canada, Ltd is a wholly-owned subsidiary of Porocel International, LLC.

The Medicine Hat facility will be Porocel’s fourth catalyst regeneration, rejuvenation and ex-situ presulphurization plant globally, adding to its other sites:  Lafayette (Louisiana), Luxembourg and Singapore. This acquisition strategically positions Porocel to service the growing Canadian catalyst market. The company will achieve growth with a focused, continued emphasis on HSE, and will be introducing new and innovative technologies tied to catalyst regeneration, rejuvenation, ex-situ presulphurization and other related catalyst processing technologies.

We look forward to having Medicine Hat in our portfolio, and to a safe & prosperous future operating in Canada.

Sponsor:

News Category:

Other News Items

  • Responsive image Better analyses. Better decisions.
  • Responsive image Chemical Treatments
  • Responsive image Solve the Industrial Data Problem
  • Responsive image FCC Refining Catalysts
  • Responsive image Top Performer in Portable Fuel Analysis
  • Responsive image Ejector Systems
  • Responsive image Smart solutions for valves and valve automation
  • Responsive image 6 - 8 May 2025,
    Dubai, UAE
  • Responsive image Level and density in FCC processes
  • Responsive image FCC catalyst solutions